What's Going On With ARS Pharmaceuticals Stock Today?
Portfolio Pulse from Ryan Gustafson
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) shares are trading higher after a recent drop in price due to the FDA's request for additional study on the company's neffy epinephrine nasal spray. Shares increased over 32% on Thursday on above-average volume. Increased short interest in the stock could be a factor in the price spike. Wedbush analyst Andreas Argyrides maintained ARS Pharmaceuticals with an Outperform and lowered the price target from $15 to $5.
September 21, 2023 | 7:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
ARS Pharmaceuticals' stock price rebounded after a drop due to FDA's request for additional study. The stock price increased over 32% on high volume. The price target was lowered from $15 to $5 by Wedbush analyst.
The stock price of ARS Pharmaceuticals rebounded after a drop due to the FDA's request for additional study on the company's product. This indicates a positive sentiment among investors despite the regulatory setback. The increase in short interest could also be contributing to the price spike. However, the lowered price target by Wedbush analyst indicates a cautious outlook for the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100